Several registered clinical trials are going to investigate the case for a KD as
a supportive therapeutic option in oncology.
Not exact matches
Supportive and symptomatic treatments are currently the only
therapeutic option to delay muscle atrophy is of critical importance in the clinics.
Information gained from this work will serve to enhance the clinical usefulness of findings from genomic sequencing (for example, next - generation sequencing or comprehensive genomic profiling), determine
therapeutic approaches based on genomic findings, aid in the development of clinical trials and related
options, and provide
supportive rationale for exploring new therapies.
I believe a compassionate and
supportive therapeutic relationship is essential; it creates a safe and non-judgmental atmosphere allowing clients to fully explore their concerns, identify their
options, and begin to make the changes they seek.